DK1066030T3 - Topical hormonal composition with systemic effect - Google Patents

Topical hormonal composition with systemic effect

Info

Publication number
DK1066030T3
DK1066030T3 DK99909078T DK99909078T DK1066030T3 DK 1066030 T3 DK1066030 T3 DK 1066030T3 DK 99909078 T DK99909078 T DK 99909078T DK 99909078 T DK99909078 T DK 99909078T DK 1066030 T3 DK1066030 T3 DK 1066030T3
Authority
DK
Denmark
Prior art keywords
systemic effect
hormonal composition
topical hormonal
topical
composition
Prior art date
Application number
DK99909078T
Other languages
Danish (da)
Inventor
Jacques Paris
Jean-Louis Thomas
Michel Lanquetin
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DK1066030T3 publication Critical patent/DK1066030T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
DK99909078T 1998-03-23 1999-03-23 Topical hormonal composition with systemic effect DK1066030T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803533A FR2776191B1 (en) 1998-03-23 1998-03-23 TOPICAL HORMONAL COMPOSITION WITH SYSTEMIC EFFECT
PCT/FR1999/000680 WO1999048477A1 (en) 1998-03-23 1999-03-23 Topical hormonal composition with systemic effect

Publications (1)

Publication Number Publication Date
DK1066030T3 true DK1066030T3 (en) 2007-06-11

Family

ID=9524367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909078T DK1066030T3 (en) 1998-03-23 1999-03-23 Topical hormonal composition with systemic effect

Country Status (29)

Country Link
US (1) US20080227763A1 (en)
EP (1) EP1066030B1 (en)
JP (1) JP4579411B2 (en)
KR (1) KR100681322B1 (en)
CN (1) CN1161102C (en)
AP (1) AP1343A (en)
AT (1) ATE353626T1 (en)
AU (1) AU754490B2 (en)
BR (1) BR9909027A (en)
CA (1) CA2324904C (en)
CY (1) CY1106463T1 (en)
CZ (1) CZ300484B6 (en)
DE (1) DE69935135T2 (en)
DK (1) DK1066030T3 (en)
ES (1) ES2283106T3 (en)
FR (1) FR2776191B1 (en)
HK (1) HK1038184A1 (en)
HU (1) HU228863B1 (en)
ID (1) ID27988A (en)
IL (1) IL138607A0 (en)
NO (1) NO331222B1 (en)
NZ (1) NZ507201A (en)
OA (1) OA11489A (en)
PL (1) PL204210B1 (en)
PT (1) PT1066030E (en)
RU (1) RU2215520C2 (en)
TR (1) TR200002751T2 (en)
WO (1) WO1999048477A1 (en)
ZA (1) ZA200005785B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030616A1 (en) 1998-11-20 2000-06-02 Rtp Pharma Inc. Dispersible phospholipid stabilized microparticles
WO2001030356A1 (en) * 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
DE10008128A1 (en) * 2000-02-22 2001-08-23 Bayer Ag Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol
KR100452972B1 (en) * 2000-05-16 2004-10-14 주식회사 삼양사 Hydrogel composition for transdermal drug
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7005557B2 (en) 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
DE10146541A1 (en) * 2001-09-21 2003-04-17 Kade Pharma Fab Gmbh Medicinal products based on progestogens for dermal use
NZ546106A (en) 2003-10-10 2008-10-31 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (en) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 Methods of treating hot flashes with formulations for transdermal or transmucosal application
US7772213B2 (en) 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (en) 2011-11-23 2021-09-30 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP2742932A1 (en) * 2012-12-17 2014-06-18 Laboratorios Ojer Pharma S.L. Gel compositions
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (en) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. Natural combination hormone replacement therapy and therapy
RU2016141135A (en) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. TRANSDERMAL CREAM
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
RU2018133932A (en) 2016-04-01 2020-05-12 Терапьютиксмд, Инк. PHARMACEUTICAL COMPOSITION OF A STEROID HORMONE
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2020161771A1 (en) * 2019-02-04 2020-08-13 マルホ株式会社 Skin composition
GB2597637A (en) * 2020-06-02 2022-02-09 Surfachem Ltd Sanitiser composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2099747T3 (en) * 1990-06-01 1997-06-01 Population Council Inc THERAPEUTICALLY EFFECTIVE TOPIC APPLICATION OF ST1435.
FR2668945B1 (en) * 1990-11-12 1993-02-19 Theramex NEW PROCESS FOR THE CRYSTALLIZATION OF ORGANIC SUBSTANCES AND THE COMPOUNDS THUS OBTAINED.
JPH05148146A (en) * 1991-06-20 1993-06-15 Terumo Corp Water-soluble gel external agent
JP2960832B2 (en) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト Estradiol administration system
FR2695826B1 (en) * 1992-09-21 1995-01-06 Theramex New pharmaceutical compositions based on nomegestrol derivatives and methods for obtaining them.
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
IL105600A (en) * 1993-05-04 1999-12-31 Allon Blank Pharmaceutical and cosmetic compositions with increased rate of transdermal penetration and antioxidation protection against degradation containing derivatives of thioglycolic and mercaptopropionic acids some such novel compounds and their use
EP0785211A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New substituted 19-nor-pregnane derivatives
EP0785212A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
JP4346696B2 (en) * 1996-05-28 2009-10-21 久光製薬株式会社 Transdermal therapeutic device
IT1283102B1 (en) * 1996-06-06 1998-04-07 Permatec Nv THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ESTROGENIC OR PROGESTINIC ACTIVE SUBSTANCE OR OF THEIR MIXTURES

Also Published As

Publication number Publication date
KR20010042152A (en) 2001-05-25
RU2215520C2 (en) 2003-11-10
HU228863B1 (en) 2013-06-28
FR2776191A1 (en) 1999-09-24
DE69935135T2 (en) 2007-10-31
CZ20003471A3 (en) 2001-07-11
AU754490B2 (en) 2002-11-21
HK1038184A1 (en) 2002-03-08
US20080227763A1 (en) 2008-09-18
CZ300484B6 (en) 2009-05-27
AP2000001948A0 (en) 2000-12-31
PL343256A1 (en) 2001-07-30
ZA200005785B (en) 2001-06-12
HUP0101579A3 (en) 2002-01-28
ATE353626T1 (en) 2007-03-15
CA2324904C (en) 2009-03-03
CN1301146A (en) 2001-06-27
KR100681322B1 (en) 2007-02-09
PT1066030E (en) 2007-05-31
JP4579411B2 (en) 2010-11-10
ID27988A (en) 2001-05-03
FR2776191B1 (en) 2002-05-31
CN1161102C (en) 2004-08-11
CY1106463T1 (en) 2012-01-25
HUP0101579A2 (en) 2001-11-28
NZ507201A (en) 2003-07-25
PL204210B1 (en) 2009-12-31
NO331222B1 (en) 2011-11-07
AU2845199A (en) 1999-10-18
BR9909027A (en) 2001-12-11
CA2324904A1 (en) 1999-09-30
EP1066030B1 (en) 2007-02-14
JP2002507561A (en) 2002-03-12
NO20004745L (en) 2000-11-20
WO1999048477A1 (en) 1999-09-30
ES2283106T3 (en) 2007-10-16
IL138607A0 (en) 2001-10-31
AP1343A (en) 2004-12-15
NO20004745D0 (en) 2000-09-22
TR200002751T2 (en) 2000-12-21
OA11489A (en) 2004-05-08
EP1066030A1 (en) 2001-01-10
DE69935135D1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
DK1066030T3 (en) Topical hormonal composition with systemic effect
DE60022162D1 (en) TOPICAL COMPOSITION WITH N-ACETYLGLUKOSAMINE
HUP0204349A3 (en) Novel topical oestroprogestational compositions with systemic effect
ID26926A (en) SHAMPO COMPOSITION FORM MODE
ID26186A (en) SAMPO COMPOSITION
NO20005913L (en) Medicinal Composition
ID29430A (en) HERBISIDE COMPOSITION
ID27415A (en) PHARMACEUTICAL COMPOSITION
ID29262A (en) PHARMACEUTICAL COMPOSITION
DE69942892D1 (en) GAS-CREATING COMPOSITION
DE69928862D1 (en) composition
DE69902473D1 (en) COSMETIC COMPOSITION
ID26370A (en) HAIR CONSTRUCTION COMPOSITION
ID27201A (en) PHARMACEUTICAL COMPOSITION
ID16929A (en) ANTI VAGINITICAL COMPOSITION FOR TOPICAL USE.
ATE269106T1 (en) GLYCOLIPIDE CREAMS
ID26295A (en) HARD-ULTRAVIOLET COMPOSITION
ID26485A (en) PAROXOXINE COMPOSITION
ID26215A (en) PHARMACEUTICAL COMPOSITION
NO20005483L (en) New composition
ID28359A (en) COMPOSITION
DE69939964D1 (en) Gel-shaped composition
ID28785A (en) COMPOSITION
DE59809275D1 (en) rolling gate
HU0002800D0 (en) Topical composition with analgetic effect